Sun Pharma arm buys Fiterman Pharma Uractiv portfolio Ruchika Sharma27 May 2022 11:59 AM ISTThe acquisition is subject to customary closing conditions and necessary regulatory approvals.
Sun Pharma arm recalls Bupropion hydrochloride ER tablets in US Ruchika Sharma23 May 2022 12:12 PM ISTThe company is recalling 9,804 bottles of 150 mg strength and 744 bottles of 200 mg strength, the US health regulator stated.
Sun Pharma arm to unveil Bempedoic Acid under brand name Brillo in India Roshni Dhar19 May 2022 6:15 PM ISTPharma major, Sun Pharmaceutical Industries Limited, has recently announced that one of its wholly-owned subsidiaries plans to launch a first-in-class...
Top Health Bulletin 19/May/2022 Roshni Dhar19 May 2022 5:00 PM ISTHere are the top health stories for today:Health ministry launches training programme on emergency life support Introducing a...
Sun Pharma arm to launch Bempedoic Acid to treat bad cholesterol in India Ruchika Sharma19 May 2022 11:00 AM ISTBrillo is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents.
Drug alert: CDSCO flags 27 medicine batches as not of standard quality Ruchika Sharma14 May 2022 2:48 PM ISTNew Delhi: In its latest drug safety alert, the Central Drugs Standard Control Organization (CDSCO) has flagged 27 medicine batches as not of Standard...
Sun Pharma bags USFDA nod for generic Mesalamine ER capsules to treat bowel disease Ruchika Sharma13 May 2022 11:49 AM ISTMumbai: Pharma major, Sun Pharmaceutical Industries Limited, has recently announced that the company has received final approval from US Food and Drug...
Sun Pharma gets 10 USFDA observations for Halol facility Ruchika Sharma10 May 2022 1:04 PM ISTMumbai: Pharma major, Sun Pharma, today announced that US Food and Drug Administration (USFDA) has recently concluded the Good Manufacturing...
Sun Pharma, Aurobindo, Jubilant recall products in US Ruchika Sharma25 April 2022 11:48 AM ISTThe USFDA has classified the recalls as Class III, which is initiated in a " situation in which use of, or exposure to, a violative product is not...
Ahead of Sitagliptin going off-Patent, NPPA moves to fix retail price of its FDC Meghna A Singhania15 April 2022 5:22 PM ISTNew Delhi: With the popular antidiabetic drug Sitagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
Fact Check: No, Sun Pharma is not giving RS 6000 worth gifts on its 40th Anniversary Dr. Divya Colin9 April 2022 3:00 PM ISTSun Pharma recently warned about recent a fake website misguiding public
Sun Pharma to market its own version of Vortioxetine, signs agreement with Lundbeck MD Bureau31 March 2022 12:02 PM ISTVortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder in adults.
